Protagenic Therapeutics, Inc. (PTIX) - Company Total Revenue
Is it worth investing in Protagenic Therapeutics (PTIX), whose patents for combating obesity and stress lay the foundation for future licensing revenues? The company's current performance metrics demonstrate demand dynamics, where the value of 0.00 expresses the state of the metric. Partnerships with scientific centers for peptide creation support the growth of business value, while the continuity of research is guaranteed by optimized raw material logistics.
Analytical breakdowns for protagenic.com (PTIX)
- current quotes and average value forecast:
- market capitalization indicators:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Protagenic Therapeutics|PTIX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Protagenic Therapeutics, Inc.|PTIX - Company Total Debt|Debt to Book Capital Protagenic Therapeutics Inc.|PTIX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Protagenic Therapeutics|Immediate Liquidity protagenic.com
- financial results and valuation multiples details:
PTIX - Company Net Income|Expected Net Income Protagenic Therapeutics|PTIX - P/E Multiple|Forward P/E Multiple protagenic.com|PTIX - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Protagenic Therapeutics Inc.|PTIX - Operating profit EBITDA|Net earnings per one share for the last twelve months Protagenic Therapeutics|PTIX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth protagenic.com|PTIX - Net earnings per share growth this year|Projected earnings per share increase next year Protagenic Therapeutics
- company sales and revenue statistics:
General company analysis:Protagenic Therapeutics, Inc., PTIX
This indicator reflects net revenue flow excluding accounting adjustments, capturing real-time market demand for the issuer's products. An analysis of Protagenic Therapeutics (PTIX) sales volume allows for an assessment of the commercial efficiency of its neurobiology developments, confirming sustained market interest in innovative antidepressants and stress-relief drugs through sales dynamics.
Key competitors
Company Sales Volume BIIB (Biogen)|Company Revenue Neurocrine Biosciences, Inc. (NBIX)|Company Revenue RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Company Sales|ACAD (ACADIA Pharmaceuticals Inc) - Company Annual Revenue|Xenon Corp - Revenue and Sales Volume|Company Sales Revenue VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Company Revenue|Company Annual Revenue CPRX (Catalyst Pharmaceuticals, Inc.)|Company Revenue Denali Therapeutics Inc|Company Total Revenue Harmony Corp HRMY|Revenue and Sales Volume BHVN|Company Sales Amylyx Pharmaceuticals AMLX|Revenue and Sales Volume TRVI (Trevi Corp)|Company Gross Revenue Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Revenue and Sales Volume|CeriBell Corp (CBLL) - Company Sales|Prothena Corp (PRTA) - Company Revenue|Company Total Revenue Alector Inc. (ALEC)|Company Sales ANNX|omeros.com (OMER) - Company Gross Revenue|Company Revenue Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Company Sales Revenue|Revenue and Sales Volume VYGR (voyagertherapeutics.com)|Company Gross Revenue Neumora Therapeutics (NMRA)|SCLX - Company Revenue|Company Total Sales Volume Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Company Revenue|CGTX - Company Gross Revenue|IKT (inhibikase.com) - Revenue and Sales Volume|cassavasciences.com (SAVA) - Company Gross Revenue|Company Sales ASRT (Assertio Therapeutics)|Company Gross Revenue Coya Therapeutics|Vistagen - Company Sales|ovidrx.com (OVID) - Company Total Revenue|Acumen Pharmaceuticals - Revenue and Sales Volume|Company Total Revenue cervomed.com|ATHE: Revenue and Sales Volume|Clene Inc - Company Sales Revenue|Company Revenue PepGen|JUNS (Jupiter Neurosciences Inc) - Company Total Sales|Company Sales RLMD (Relmada Corp)|annovisbio.com - Company Sales Volume|Company Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Annual Revenue|KLTO - Company Revenue|Company Total Revenue NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Revenue|Company Sales Volume MTVA|Company Sales NRXS|Company Sales Helius Medical (HSDT)|Revenue and Sales Volume PASG|Neuphoria Therapeutics - Company Sales Volume|Company Revenue Minerva Neurosciences, Inc. NERV|Revenue and Sales Volume Athira Pharma ATHA|ADXN: Company Sales|Company Total Revenue Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Revenue|KTTA: Company Total Sales|CRGT (cortigent.com) - Revenue and Sales Volume|ATXI (Avenue Therapeutics) - Company Total Sales|Revenue and Sales Volume BCLI|Company Total Sales CARA|Company Revenue chromocell.com CHRO|Revenue and Sales Volume Eliem Therapeutics ELYM|ITCI: Company Sales|LBPH: Company Revenue|MRNS (Marinus Pharmaceuticals, Inc.) - Company Sales|NKGen - Company Sales Revenue|Company Revenue NeuroBo Pharmaceuticals, Inc.|Revenue and Sales Volume Sage Therapeutics Inc|Revenue and Sales Volume SNPX|TRVN - Company Total Revenue|Company Revenue vigilneuro.com VIGL|Company Gross Revenue Anew Medical (WENA)|cerevel.com - Revenue and Sales Volume
